ar-Turmerone
Based on 1 Customer Validation
ar-Turmerone ((+)-ar-Turmerone) is an orally active and major bioactive compound of the herb Curcuma longa with anti-tumorigenesis and anti-inflammatory activities. ar-Turmerone induces apoptosis in U937 cells. ar-Turmerone exerts positive modulation on murine DCs. ar-Turmerone induces NSC proliferation in vitro and in vivo, and can be used for various neurologic disorders study.
For research use only. We do not sell to patients.
- Purity: 99.00%
- CAS No.: 532-65-0
- Formula: C15H20O
- Molecular Weight:216.32
-
Storage:Pure form -20°C, 3 years ; In solvent -80°C, 6 months , -20°C, 1 month
To place orders, for customer services and technical support, please contact: MedChemExpress USA
Tel: 609-228-6898 E-mail: [email protected] [email protected]
-
Biological Activity
-
Chemical Information
-
Solvent & Solubility
- Purity & Documentation
- References
-
Help & FAQs
-
Apoptosis Compound Library
HY-L003
-
Immunology/Inflammation Compound Library
HY-L007
-
Natural Product Library
HY-L021
-
Anti-Cancer Compound Library
HY-L025
-
Medicine Food Homology Compound Library
HY-L055
-
Orally Active Compound Library
HY-L061
-
Traditional Chinese Medicine Active Compound Library
HY-L065
-
Food-Sourced Compound Library
HY-L094
-
Anti-Cancer Natural Product Library
HY-L107
-
Anti-inflammatory Traditional Chinese Medicine Active Compound Library
HY-L114
-
Plant-Sourced Natural Product Library
HY-L115
-
Human Metabolite Library
HY-L123
-
Cell Death Library
HY-L162
-
Bioactive Compound Library Max
HY-L181
-
MCE Bioactive Compound Library
HY-L001V
-
Natural Product Library Plus
HY-L021P
-
Natural Product and Natural Product-Like Compound Library
HY-L021M
-
Bioactive Compound Library
HY-L001
-
Pesticide Compound Library
HY-L183
-
Miao Ethnicity Medicine Compound Library
HY-L190
-
PBCRBS Traditional Chinese Medicine Compound Library
HY-L193
-
Heat-Clearing and Detoxification Traditional Chinese Medicine Compound Library
HY-L194
-
Protein Kinase Compound Library
HY-L196
-
Non-Alcoholic Fatty Liver Disease (NAFLD) Compound Library
HY-L199
-
RO5 Drug-like Natural Product Library
HY-L200
-
High-Throughput Bioactive Compound Library
HY-L205
-
High-Throughput Natural Product Library
HY-L206
-
Ancient Chinese Classical Formulas Traditional Chinese Medicine Active Compound Library
HY-L209
-
Mass Spectrometry Human Metabolite Library
HY-L215
-
Antitussive and Antiasthmatic Traditional Chinese Medicine Active Compound Library
HY-L223
-
Diarrhea-Related Traditional Chinese Medicine Active Compound Library
HY-L224
-
Mongolian Medicine Compound Library
HY-L238
-
Mass Spectrometry Natural Product Library
HY-L262
Biological Activity
ar-Turmerone (3.125-160 μg/mL, 24 or 48 h) inhibits cell viability in cancer cells[2][3].
ar-Turmerone (5-15μg/mL, 72 or 24 h) exhibits stimulating effects on PBMC proliferation and cytokine production[2].
ar-Turmerone (40-160 μg/mL, 48 h) induces apoptosis on U937 cells may involve caspase-3 activation through the induction of Bax and p53[3].
ar-Turmerone (1.5625-400 µg/mL, 24-96 h) increases the production of IL-12 and tumor necrosis factor α (TNF-α), promotes phenotypic and functional maturation in murine dendritic cells (DCs)[4].
ar-Turmerone (1.56-25 μg/mL, 72 h) increases fetal rat neural stem cells (NSCs) proliferation in vitro[5].
ar-Turmerone (6.25 μg/mL, 10 days) increases fetal rat NSC neurogenesis in vitro[5].
MedChemExpress (MCE) has not independently confirmed the accuracy of these methods. They are for reference only.
-
Cell Line:HepG2, MCF-7, MDA-MB-231, Hs-68 (human skin fibroblast cell line)
-
Concentration:3.125-100 μg/mL
-
Incubation Time:48 h
-
Result:Showed anti-proliferative activities in HepG2, MCF-7 cells and MDA-MB-231 cells in a concentration-dependent manner.
Did not show significant suppression on the proliferation of Hs-68.
-
Cell Line:PBMC (human peripheral blood mononuclear cells)
-
Concentration:5, 10, 15 μg/mL
-
Incubation Time:72 h or 24 h
-
Result:Significantly stimulate the proliferation of PHA-activated PBMC.
Did not alter the proliferative response of resting PBMC (without mitogen).
Increased TNF-α production at 10 and 15 μg/ml in PHA-activated PBMC.
Significantly increased TNF-α, IL-2 and IFN-γ productions in resting PBMC.
-
Cell Line:U937 cells
-
Concentration:40, 80, 120, 160 μg/mL
-
Incubation Time:24 or 48 h
-
Result:Showed a dose dependent inhibitory effect in U937 cell proliferation.
The viability was inhibited 61, 68, 81 and 84% at 40, 80, 120 and 160 μg/mL for 48 h incubation, respectively. Induced clear apoptosis in U937 cells in the range of 80-160 μg/mL.
-
Cell Line:U937 cells
-
Concentration:40, 80, 120, 160 μg/mL
-
Incubation Time:48 h
-
Result:Did not affect the levels of Bcl-2 mRNA.
The levels of Bax mRNA were significantly induced in a concentration-dependent manner.
The levels of the mRNA of p21 remained unchanged, but the mRNA levels of p53 were significantly increased.
-
Cell Line:U937 cells
-
Concentration:40, 80, 120, 160 μg/mL
-
Incubation Time:48 h
-
Result:Did not affect the levels of Bcl-2 protein.
The levels of Bax protein were significantly induced in a concentration-dependent manner.
The levels of the protein of p21 remained unchanged, but the protein levels of p53 were significantly increased.
MedChemExpress (MCE) has not independently confirmed the accuracy of these methods. They are for reference only.
-
Animal Model:Repeated intraperitoneal injections of Lipopolysaccharides (LPS) (HY-D1056) in C57BL/6 mice. [5]
-
Dosage:100 mg/kg
-
Administration:Oral gavage (p.o.); daily for 14 days
-
Result:Mitigated the impairment of spatial learning and reference memory in mice.
Reversed the effect of LPS induced TNF-α and IL-1βin hippocampal and cortex.
The number of normal neurons and morphological characteristics were partially restored.
Increased neuronal survival in both the hippocampus and cortex.
Chemical Information
-
CAS No. 532-65-0
-
Appearance Liquid (Density: 0.945 g/cm3)
-
Molecular Weight 216.32
-
Formula C15H20O
-
Color Colorless to light yellow
-
SMILES
CC1=CC=C(C=C1)[C@H](CC(/C=C(C)\C)=O)C
-
Synonyms
(+)-ar-Turmerone
-
Structure Classification
-
Initial Source
-
Shipping
Room temperature in continental US; may vary elsewhere.
-
Storage
Pure form -20°C 3 years In solvent -80°C 6 months -20°C 1 month
Solvent & Solubility
Ethanol : 50 mg/mL (231.14 mM; Need ultrasonic)
Please refer to the solubility information to select the appropriate solvent. Once prepared, please aliquot and store the solution to prevent product inactivation from repeated freeze-thaw cycles.
Storage method and period of stock solution: -80°C, 6 months; -20°C, 1 month. When stored at -80°C, please use it within 6 months. When stored at -20°C, please use it within 1 month.
Please refer to the solubility information to select the appropriate solvent. Once prepared, please aliquot and store the solution to prevent product inactivation from repeated freeze-thaw cycles.
Storage method and period of stock solution: -80°C, 6 months; -20°C, 1 month. When stored at -80°C, please use it within 6 months. When stored at -20°C, please use it within 1 month.
Concentration (start) × Volume (start) = Concentration (final) × Volume (final)
Select the appropriate dissolution method based on your experimental animal and administration route.
- For the following dissolution methods, please ensure to first prepare a clear stock solution using an In Vitro approach and then sequentially add co-solvents:
- To ensure reliable experimental results, the clarified stock solution can be appropriately stored based on storage conditions. As for the working solution for In Vivo experiments, it is recommended to prepare freshly and use it on the same day.
- The percentages shown for the solvents indicate their volumetric ratio in the final prepared solution. If precipitation or phase separation occurs during preparation, heat and/or sonication can be used to aid dissolution.
Add each solvent one by one: 10% EtOH 40% PEG300 5% Tween-80 45% Saline
Solubility: ≥ 0.62 mg/mL (2.87 mM); Clear solution
This protocol yields a clear solution of ≥ 0.62 mg/mL (saturation unknown).
Taking 1 mL working solution as an example, add 100 μL EtOH stock solution (6.2 mg/mL) to 400 μL PEG300, and mix evenly; then add 50 μL Tween-80 and mix evenly; then add 450 μL Saline to adjust the volume to 1 mL.
Preparation of Saline: Dissolve 0.9 g sodium chloride in ddH₂O and dilute to 100 mL to obtain a clear Saline solution.
Add each solvent one by one: 10% EtOH 90% Corn Oil
Solubility: ≥ 0.62 mg/mL (2.87 mM); Clear solution
This protocol yields a clear solution of ≥ 0.62 mg/mL (saturation unknown). If the continuous dosing period exceeds half a month, please choose this protocol carefully.
Taking 1 mL working solution as an example, add 100 μL EtOH stock solution (6.2 mg/mL) to 900 μL Corn oil, and mix evenly.
Please enter the basic information of animal experiments:
-
-
-
-
Recommended: Prepare an additional quantity of animals to account for potential losses during experiments.
Working solution concentration: 0.22 mg/mL
Purity & Documentation
-
Data Sheet (278 KB)
-
SDS (537 KB)
- English - EN (537 KB)
- Français - FR (537 KB)
- Deutsch - DE (537 KB)
- Norwegian - NO (537 KB)
- Español - ES (537 KB)
- Swedish - SV (537 KB)
- Italian - IT (537 KB)
- Korean - KR (537 KB)
- Portuguese - PT (537 KB)
-
Handling Instructions (2659 KB)
References
[1]. Liju VB, et al. An evaluation of antioxidant, anti-inflammatory, and antinociceptive activities of essential oil from Curcuma longa. L. Indian J Pharmacol. 2011 Sep;43(5):526-31. [Content Brief]
[2]. Yue GG, et al. Evaluation of in vitro anti-proliferative and immunomodulatory activities of compounds isolated from Curcuma longa. Food Chem Toxicol. 2010 Aug-Sep;48(8-9):2011-20. [Content Brief]
[3]. Lee Y, et al. Activation of apoptotic protein in U937 cells by a component of turmeric oil. BMB Rep. 2009 Feb 28;42(2):96-100. [Content Brief]
[4]. Yonggang T, et al. Maturation and upregulation of functions of murine dendritic cells (DCs) under the influence of purified aromatic-turmerone (AR). Hum Vaccin Immunother. 2012 Oct;8(10):1416-24. [Content Brief]
[5]. Zhou W, et al. Structural optimization of naturally derived Ar-turmerone, as novel neuroinflammation suppressors effective in an Alzheimer mouse model. Bioorg Med Chem. 2025 Jan 1;117:118014. [Content Brief]
Complete Stock Solution Preparation Table
Please refer to the solubility information to select the appropriate solvent. Once prepared, please aliquot and store the solution to prevent product inactivation from repeated freeze-thaw cycles.
Storage method and period of stock solution: -80°C, 6 months; -20°C, 1 month. When stored at -80°C, please use it within 6 months. When stored at -20°C, please use it within 1 month.
| Optional Solvent | Concentration Solvent Mass | 1 mg | 5 mg | 10 mg | 25 mg |
|---|---|---|---|---|---|
| Ethanol | 1 mM | 4.6228 mL | 23.1139 mL | 46.2278 mL | 115.5695 mL |
| 5 mM | 0.9246 mL | 4.6228 mL | 9.2456 mL | 23.1139 mL | |
| 10 mM | 0.4623 mL | 2.3114 mL | 4.6228 mL | 11.5570 mL | |
| 15 mM | 0.3082 mL | 1.5409 mL | 3.0819 mL | 7.7046 mL | |
| 20 mM | 0.2311 mL | 1.1557 mL | 2.3114 mL | 5.7785 mL | |
| 25 mM | 0.1849 mL | 0.9246 mL | 1.8491 mL | 4.6228 mL | |
| 30 mM | 0.1541 mL | 0.7705 mL | 1.5409 mL | 3.8523 mL | |
| 40 mM | 0.1156 mL | 0.5778 mL | 1.1557 mL | 2.8892 mL | |
| 50 mM | 0.0925 mL | 0.4623 mL | 0.9246 mL | 2.3114 mL | |
| 60 mM | 0.0770 mL | 0.3852 mL | 0.7705 mL | 1.9262 mL | |
| 80 mM | 0.0578 mL | 0.2889 mL | 0.5778 mL | 1.4446 mL | |
| 100 mM | 0.0462 mL | 0.2311 mL | 0.4623 mL | 1.1557 mL |
ar-Turmerone Related Classifications
HY-N6703 Related Classifications
Powered by Bioz